Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.
Birkeland AC, Yanik M, Tillman BN, Scott MV, Foltin SK, Mann JE, Michmerhuizen NL, Ludwig ML, Sandelski MM, Komarck CM, Carey TE, Prince ME, Bradford CR, McHugh JB, Spector ME, Brenner JC. Birkeland AC, et al. Among authors: mann je. JAMA Otolaryngol Head Neck Surg. 2016 Jun 1;142(6):559-67. doi: 10.1001/jamaoto.2016.0335. JAMA Otolaryngol Head Neck Surg. 2016. PMID: 27077364 Free PMC article.
Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma.
Hoesli R, Birkeland AC, Rosko AJ, Issa M, Chow KL, Michmerhuizen NL, Mann JE, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, McHugh JB, Brenner JC, Spector ME. Hoesli R, et al. Among authors: mann je. Oral Oncol. 2018 Feb;77:83-89. doi: 10.1016/j.oraloncology.2017.12.003. Epub 2017 Dec 23. Oral Oncol. 2018. PMID: 29362129 Free PMC article.
Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.
Mann JE, Smith JD, Birkeland AC, Bellile E, Swiecicki P, Mierzwa M, Chinn SB, Shuman AG, Malloy KM, Casper KA, McLean SA, Moyer JS, Wolf GT, Bradford CR, Prince ME, Carey TE, McHugh JB, Spector ME, Brenner JC. Mann JE, et al. Cancer Immunol Immunother. 2019 Feb;68(2):213-220. doi: 10.1007/s00262-018-2256-3. Epub 2018 Oct 25. Cancer Immunol Immunother. 2019. PMID: 30361882 Free PMC article.
The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines.
Ludwig ML, Kulkarni A, Birkeland AC, Michmerhuizen NL, Foltin SK, Mann JE, Hoesli RC, Devenport SN, Jewell BM, Shuman AG, Spector ME, Carey TE, Jiang H, Brenner JC. Ludwig ML, et al. Among authors: mann je. Oral Oncol. 2018 Dec;87:144-151. doi: 10.1016/j.oraloncology.2018.10.031. Epub 2018 Nov 8. Oral Oncol. 2018. PMID: 30527230 Free PMC article.
Novel Immunotherapeutic Approaches in Head and Neck Cancer.
Heft Neal ME, Haring CT, Mann JE, Brenner JC, Spector ME, Swiecicki PL. Heft Neal ME, et al. Among authors: mann je. J Cancer Metastasis Treat. 2019;5:76. doi: 10.20517/2394-4722.2019.32. Epub 2019 Nov 22. J Cancer Metastasis Treat. 2019. PMID: 32661502 Free PMC article.
Prognostic value of CD103+ tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinoma.
Smith JD, Bellile EL, Ellsperman SE, Heft-Neal ME, Mann JE, Birkeland AC, Hoesli RC, Swiecicki PL, Worden FP, Schonewolf C, Shah JL, Mierzwa ML, Rosko AJ, Stucken CL, Chinn SB, Shuman AG, Casper KA, Malloy KM, Prince MEP, Wolf GT, Thomas DG, McHugh JB, Chad Brenner J, Spector ME. Smith JD, et al. Among authors: mann je. Oral Oncol. 2022 Dec;135:106226. doi: 10.1016/j.oraloncology.2022.106226. Epub 2022 Oct 28. Oral Oncol. 2022. PMID: 36323071 Free PMC article.
69 results